Part of a comprehensive analysis of the Medicines Act 1975
All Parts in This Series
Key Provisions of the Medicines Act 1975 and Their Purpose
The Medicines Act 1975 establishes a comprehensive regulatory framework governing the sale, supply, and quality of medicinal products in Singapore. The key provisions within this Act serve to protect public health by ensuring that medicinal products are safely dispensed, properly supervised, and meet prescribed standards. Below is an analysis of the principal sections and their underlying purposes.
"The Minister may by order specify descriptions or classes of medicinal products... which can with reasonable safety be sold or supplied otherwise than by or under the supervision of a pharmacist." — Section 23, Medicines Act 1975
Verify Section 23 in source document →
Section 23 empowers the Minister to designate certain medicinal products as suitable for general sale without pharmacist supervision. This provision exists to balance public access to low-risk medicines with safety concerns, allowing non-prescription sales of products deemed safe for unsupervised use.
"A person must not sell by retail or supply... any medicinal product which is not a medicinal product on a general sale list, unless that person is or acts under the personal supervision of a pharmacist." — Section 24, Medicines Act 1975
Verify Section 24 in source document →
Section 24 imposes a strict requirement that medicinal products outside the general sale list can only be sold or supplied under the personal supervision of a pharmacist. This ensures that higher-risk medicines are dispensed with professional oversight, reducing the risk of misuse or harm.
"This Act does not prevent any person from selling by retail or supplying... any medicinal product on a general sale list subject to any conditions that may be prescribed." — Section 25, Medicines Act 1975
Verify Section 25 in source document →
Section 25 clarifies that the sale or supply of general sale list medicines is permitted, but may be subject to conditions prescribed by the Minister. This provision allows regulatory flexibility to impose safeguards such as packaging or labeling requirements to maintain safety standards.
"A medicinal product must not be sold by means of an automatic machine unless it is a medicinal product in the automatic machine section of a general sale list and complies with any conditions that may be prescribed." — Section 26, Medicines Act 1975
Verify Section 26 in source document →
Section 26 restricts the sale of medicinal products through vending machines to those specified in the automatic machine section of the general sale list, subject to conditions. This provision exists to prevent unsupervised access to potentially harmful medicines via automated means.
"Exemptions for doctors, dentists, veterinary surgeons, and herbal remedies from restrictions in section 24." — Section 27, Medicines Act 1975
Verify Section 27 in source document →
Section 27 provides exemptions from pharmacist supervision for certain professionals and specific categories of remedies. This acknowledges the expertise of these practitioners and the traditional use of herbal remedies, facilitating their legitimate practice while maintaining overall regulatory control.
"The Minister may by order provide that section 24 has effect subject to such exemptions... as may be specified in the order." — Section 28, Medicines Act 1975
Verify Section 28 in source document →
Section 28 grants the Minister discretion to specify further exemptions to the pharmacist supervision requirement, allowing the regulatory framework to adapt to evolving medical and commercial practices.
"The Minister may by order specify descriptions or classes of medicinal products... a person must not sell by retail... a medicinal product... except in accordance with a prescription given by an appropriate practitioner." — Section 29, Medicines Act 1975
Verify Section 29 in source document →
Section 29 enables the Minister to designate certain medicines as prescription-only, ensuring that their sale is controlled and contingent upon professional medical advice. This protects consumers from the risks associated with unsupervised use of potent or hazardous medicines.
"The Minister may... prohibit the sale or supply, or the import, of medicinal products of any description... in the interests of safety." — Section 30, Medicines Act 1975
Verify Section 30 in source document →
Section 30 empowers the Minister to prohibit the sale, supply, or import of medicinal products deemed unsafe. This provision is crucial for public health protection, allowing swift regulatory action against harmful or substandard medicines.
"Prohibition on adulteration of medicinal products." — Section 31, Medicines Act 1975
Verify Section 31 in source document →
Section 31 prohibits adulteration, ensuring that medicinal products are not tampered with or contaminated, thereby safeguarding their efficacy and safety.
"Protection of purchasers: A person must not... sell any medicinal product which is not of the nature or quality demanded by the purchaser." — Section 32, Medicines Act 1975
Verify Section 32 in source document →
Section 32 protects consumers by mandating that medicinal products sold must conform to the quality and nature expected by the purchaser, preventing fraud and ensuring trust in the pharmaceutical market.
"Compliance with standards specified in monographs in certain publications." — Section 33, Medicines Act 1975
Verify Section 33 in source document →
Section 33 requires medicinal products to comply with standards set out in recognized pharmacopoeias and codices. This ensures uniform quality and safety benchmarks are met, facilitating regulatory oversight and consumer confidence.
"The Minister may by regulations prescribe any requirements... with respect to... preparation, dispensing, premises, safekeeping, disposal, records, sanitation, and automatic machines." — Section 34, Medicines Act 1975
Verify Section 34 in source document →
Section 34 authorizes the Minister to prescribe detailed regulations governing the handling and management of medicinal products, ensuring comprehensive control over all aspects of their lifecycle to maintain safety and efficacy.
"Offences and penalties for contraventions of sections 24, 26, 29, 31, 32, 33, and orders under section 30." — Section 35, Medicines Act 1975
Verify Section 35 in source document →
Section 35 establishes the legal consequences for non-compliance with key provisions, reinforcing the seriousness of regulatory adherence and deterring violations that could endanger public health.
Definitions Relevant to the Medicines Act 1975
Precise definitions within the Act provide clarity and ensure consistent application of its provisions.
"Any reference to a medicinal product on a general sale list is a reference to a medicinal product of a description, or falling within a class, specified in an order under this section which is for the time being in force." — Section 23(2), Medicines Act 1975
Verify Section 23 in source document →
This definition clarifies that the general sale list is dynamic and determined by Ministerial orders, allowing regulatory flexibility to update the list as needed.
"Definitions of 'publication' and 'the relevant monograph' including 'British Pharmacopoeia, the European Pharmacopoeia or the United States Pharmacopoeia, the British Pharmaceutical Codex and the British Veterinary Codex.'" — Section 33(4), Medicines Act 1975
Verify Section 33 in source document →
Section 33(4) identifies authoritative sources for medicinal product standards, ensuring that quality benchmarks are internationally recognized and scientifically sound.
"Definition of 'the appropriate current monograph.'" — Section 33(5), Medicines Act 1975
Verify Section 33 in source document →
This provision specifies that the applicable monograph is the one current at the time of manufacture or supply, ensuring that products meet the latest standards.
"Definition of 'current' edition of a publication." — Section 33(6), Medicines Act 1975
Verify Section 33 in source document →
Section 33(6) defines what constitutes a current edition, providing certainty in the application of standards and preventing ambiguity.
Penalties for Non-Compliance Under the Medicines Act 1975
The Act imposes stringent penalties to enforce compliance and protect public health.
"Any person who contravenes section 24, 26, 29, 31, 32 or 33 or who contravenes any order made under section 30, shall be guilty of an offence." — Section 35(1), Medicines Act 1975
Verify Section 35 in source document →
This subsection establishes that violations of critical provisions related to sale, supply, safety, and quality constitute offences, underscoring the importance of adherence.
"Any person who... is in possession of the medicinal product, knowing or having reasonable cause to suspect that it was sold, supplied or imported in contravention of the order, shall be guilty of an offence." — Section 35(2), Medicines Act 1975
Verify Section 35 in source document →
Section 35(2) extends liability to possession of illicit medicinal products, preventing the circulation of unsafe medicines and encouraging vigilance among handlers.
"Any person guilty of an offence under subsection (1) or (2) shall be liable on conviction to a fine not exceeding $5,000 or to imprisonment for a term not exceeding 2 years or to both." — Section 35(3), Medicines Act 1975
Verify Section 35 in source document →
This provision sets out the maximum penalties, reflecting the seriousness of offences and serving as a deterrent against breaches that could harm public health.
"Any person who contravenes any conditions prescribed for the purpose of section 25 shall be guilty of an offence and shall be liable on conviction to a fine not exceeding $2,000." — Section 35(4), Medicines Act 1975
Verify Section 35 in source document →
Section 35(4) imposes penalties for failure to comply with conditions related to general sale list medicines, ensuring that even lower-risk products are subject to regulatory controls.
Cross-References to Other Legislation
The Medicines Act 1975 acknowledges the interplay with other written laws to ensure coherent regulatory enforcement.
"Otherwise than for the purpose of performing or exercising a duty or power imposed or conferred by or under this Act or any other written law." — Section 35(2), Medicines Act 1975
Verify Section 35 in source document →
This phrase indicates that certain actions permitted under this Act or other laws do not constitute offences, recognizing the broader legal framework within which medicinal product regulation operates. It ensures that authorised activities under other statutes are not inadvertently penalized under the Medicines Act.
Conclusion
The Medicines Act 1975 meticulously regulates the sale, supply, and quality of medicinal products in Singapore. Its provisions are designed to safeguard public health by controlling access to medicines, ensuring professional supervision where necessary, maintaining product standards, and enforcing compliance through penalties. The Act’s flexibility through Ministerial orders and regulations allows it to adapt to changing medical and commercial landscapes while maintaining rigorous safety standards.
Sections Covered in This Analysis
- Section 23 – General Sale List and Ministerial Orders
- Section 24 – Sale and Supply Under Pharmacist Supervision
- Section 25 – Sale of General Sale List Medicines
- Section 26 – Sale by Automatic Machines
- Section 27 – Exemptions for Certain Practitioners and Remedies
- Section 28 – Ministerial Exemptions to Section 24
- Section 29 – Prescription-Only Medicines
- Section 30 – Prohibition of Unsafe Medicinal Products
- Section 31 – Prohibition on Adulteration
- Section 32 – Protection of Purchasers
- Section 33 – Compliance with Pharmacopoeial Standards
- Section 34 – Ministerial Regulations on Handling and Dispensing
- Section 35 – Offences and Penalties
Source Documents
For the authoritative text, consult SSO.